Name Terbinafine solution dnar.prim. , T. verrucosum, T. violaceum), Microsporum canis and Epidermopyton floccosum; versicolor versicolor caused by Pityrosporum orbiculare (also known as Malassezia furfur). Dosage and administration The drug is intended for use in adults and children over 12 years of age. Terbinafine is used once or twice a day, depending on the indication. Before using the drug, it is necessary to thoroughly clean and dry the affected areas. The solution is applied to the affected areas and adjacent intact skin areas in an amount sufficient to thoroughly moisturize them, if necessary using cotton swabs to optimize this process. The place of application of the drug is covered with a gauze bandage. Duration of treatment and frequency of use of the drug: ringworm of the trunk, legs – 1 time per day for 1 week; tinea pedis – 1 time per day for 1 week; versicolor versicolor – 2 times a day for 1 week. The efficacy and safety of terbinafine solution for the treatment of moccasin-type foot mycoses, as well as severe foot mycoses with concomitant onychomycosis, have not been studied. A decrease in the severity of clinical manifestations is noted in the first days of treatment. In case of irregular treatment or its premature termination, there is a risk of recurrence of the infection. In the event that after a week of treatment there are no signs of improvement, the diagnosis should be verified. Application during pregnancy and lactation Due to the fact that there are no data on the safety of terbinafine during pregnancy and lactation, the drug should be prescribed only in cases where the expected positive effect in the mother outweighs the potential risk to the fetus. It is known that terbinafine is excreted in breast milk, so the drug should not be administered during breastfeeding. Precautions Terbinafine solution is for external use only. The solution should not be applied to the face. Avoid contact with eyes as it may cause irritation. In case of accidental contact of the drug with the eyes, they should be rinsed with running water. Care should be taken when applying Terbinafine to damaged areas of the skin, as the composition of the drug contains alcohol, which can cause irritation. The propylene glycol contained in this medicine may cause skin irritation. When treating with Terbinafine, general hygiene rules should be observed to prevent the possibility of re-infection (through underwear, shoes, etc.). Interaction with other drugs The interaction of terbinafine topical solution with other drugs is unknown. Contraindications Hypersensitivity to terbinafine or to any of the excipients that make up the drug. With caution Renal / liver failure, alcoholism, oppression of bone marrow hematopoiesis, tumors, metabolic diseases, occlusive diseases of the vessels of the extremities. Use in children Do not use the drug in children under the age of 5 years due to the lack of clinical data. There is not enough data on the safety and efficacy of the drug in children under 12 years of age. Elderly patients Dose adjustment is not required. Side effects do not differ from those observed in patients of other age groups. Composition 1 ml of solution contains 10 mg of terbinafine hydrochloride as an active substance. Excipients: ethyl alcohol, purified water, macrogol 400, propylene glycol. Overdose There are no data on overdose with topical application of Terbinafine. If by chance the solution is taken orally, side effects such as headache, nausea, epigastric pain and dizziness can be expected. In such cases, gastric lavage and/or supportive symptomatic treatment may be necessary. The content of alcohol in the drug (23.5%) should also be taken into account. Treatment: activated charcoal, if necessary – symptomatic supportive therapy in a hospital setting. Side effectsRedness, itching or burning sensation, skin peeling, pain or irritation may appear at the sites of application of the solution, but discontinuation of treatment due to these phenomena is rarely required. These less serious side effects should be distinguished from rare allergic reactions (eg, generalized rash and / or redness, urticaria, angioedema, repeated allergic reaction), the development of which requires discontinuation of treatment. In rare cases, an exacerbation of a fungal infection is possible. If the listed adverse reactions occur, as well as reactions not listed in the package leaflet, you should consult a doctor. Storage conditionsKeep in a place protected from light at a temperature not exceeding 25°C. Keep out of the reach of children. Buy Terbinafine solution for external use 10mg/1ml 25ml №1
INN | TERBINAFIN |
---|---|
The code | 46 546 |
Barcode | 4 810 183 005 480 |
Dosage | 10mg/1ml 25ml |
Active substance | Terbinafine |
Manufacturer | Pharmtekhnologiya LLC, Belarus |
Reviews
There are no reviews yet.